An unusual DNA structure may hold the key to treating one of the deadliest cancers affecting women, which claims more than ...

Researchers at Washington University School of Medicine in St. Louis have revealed the structure of a key protein involved in ...

--Assembly Biosciences, Inc., a biotechnology company developing innovative therapeutics targeting serious viral diseases, today announced that the first participant has been dosed in the Phase 1 ...

Not all DNA looks like the familiar twisted ladder. Sometimes, parts of our genetic code fold into unusual shapes. One such structure, the G-quadruplex (G4), looks like a knot. These knots can ...

Scientists studying ancient human remains uncovered in Colombia have found that the people they were researching have no known ancestors or modern descendants.

Court records show the private lab that did the testing, Bode Technology Group Inc., lost the evidence and it can’t be retested.

Bayer’s Vividion Therapeutics has secured the global rights from its partner Roche to the only Werner helicase inhibitor to have made it into the clinic.

The switch from fetal γ-globin to adult β-globin is controlled by BCL11A. Genetic manipulation of BCL11A improves disease outcomes by turning γ-globin expression back on to compensate for ...

Researchers from Geneseeq and a network of Chinese academic hospitals have validated a blood test that can detect a broad range of cancers with high accuracy using cell-free DNA. A multi-cancer ...

A team of researchers has used advanced DNA sequencing to develop the most comprehensive atlas yet of genetic change through generations, laying the foundations for new insights into the roots of ...

G-quadruplex (G4) is a unique nucleic acid secondary structure formed by guanine-rich DNA or RNA sequences through Hoogsteen hydrogen bonding among four guanines.

A recent study shows how extrachromosomal DNA contributes to tumor heterogeneity and may drive cancer progression.